• Title/Summary/Keyword: Living Donors

Search Result 43, Processing Time 0.024 seconds

Efficacy of Hepatitis B Immune Globulin for Prevention of De Novo Hepatitis B in Living-related Liver Transplantation (생체 부분 간이식에서 De Novo Hepatitis B에 대한 B형 간염 면역글로불린의 예방적 효과)

  • Kim, Sang-Jong;Hwang, Soo-Jung;Park, Sung-Eun;Choe, Yon-Ho;Lee, Suk-Koo;Joh, Jae-Won;Kim, Sung-Joo;Lee, Kwang-Woong;Seo, Jeong-Meen
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • v.6 no.1
    • /
    • pp.32-38
    • /
    • 2003
  • Purpose: Hepatic allografts from donors with hepatitis B core antibody have been demonstrated to transmit hepatitis B virus (HBV) infection to recipients after liver transplantation (LT). The efficacy of hepatitis B immune globulin (HBIg) to prevent de novo hepatitis B was investigated by comparing active immunization in the early phase to HBIg monotherapy in the late phase of pediatric liver transplants at Samsung Medical Center. Methods: Among pediatric liver transplants, from May, 1996 to June, 2002, 15 recipients who were hepatitis B surface antigen (HBsAg) (-) received an allograft from a donor with hepatitis B core antibody (HBcAb) (+). Except two who died from unrelated causes, eleven of 13 recipients were HBsAb (+), and 2 were naive (HBsAb(-), HBcAb(-)). All patients were vaccinated for HBV before LT. In the early phase (January, 1997~November, 1997, 3 patients), HBsAb (+) recipients received booster vaccination after LT. In the late phase (December, 1997~, 10 patients), all recipients were given booster vaccination and received HBIg therapy in order to maintain HBsAb titer greater than 200 IU/L. Lamivudine was given in one case because of severe side effect of HBIg. We retrospectively analyzed the effect of the preventive therapy for de novo hepatitis B through medical records. Results: De novo hepatitis B developed in three of 13 recipients (23.1%). All of 3 patients who received active immunization in the early phase became HBsAg (+) at 7~19 months after transplantation. One of them was naive before LT and the other two were HBsAb (+). All of 10 recipients who were given HBIg in the late phase remained HBsAg (-) at 7~55 months' follow-up. Conclusion: Passive immunization with HBIg was effective for prevention of de novo hepatitis B in HBsAg (-) recipients of hepatic allografts from HBcAb (+) donors.

  • PDF

Mechanism of Biological Nitrogen Fixation in Azotobacter vinelandii (Azotobacter vinelandii에서의 생물학적 질소고정 작용 메카니즘)

  • Kim, Yong-Ung;Han, Jae-Hong
    • Applied Biological Chemistry
    • /
    • v.48 no.3
    • /
    • pp.189-200
    • /
    • 2005
  • Biological nitrogen fixation is an important process for academic and industrial aspects. This review will briefly compare industrial and biological nitrogen fixation and cover the characteristics of biological nitrogen fixation studied in Azotobacter vinelandii. Various organisms can carry out biological nitrogen fixation and recently the researches on the reaction mechanism were concentrated on the free-living microorganism, A. vinelandii. Nitrogen fixation, which transforms atmospheric $N_2$ into ammonia, is chemically a reduction reaction requiring electron donation. Nitrogenase, the biological nitrgen fixer, accepts electrons from biological electron donors, and transfers them to the active site, FeMo-cofactor, through $Fe_4S_4$ cluster in Fe protein and P-cluster in MoFe protein. The electron transport and the proton transport are very important processes in the nitrogenase catalysis to understand its reaction mechanism, and the interactions between FeMo-cofactor and nitrogen molecule are at the center of biological nitrogen fixation mechanism. Spectroscopic studies including protein X-ray crystallography, EPR and $M{\ddot{o}}ssbauer$, biochemical approaches including substrate and inhibitor interactions as well as site-directed mutation study, and chemical approach to synthesize the FeMo-cofactor model compounds were used for biological nitrogen fixation study. Recent research results from these area were presented, and finally, a new nitrogenase reaction mechanism will be proposed based on the various research results.

Trends of Thermochemical Technology for the Recovery of Phosphorus from Sewage Sludge Ash (열화학적 방법에 의한 하수 슬러지 소각재에서의 인 회수 기술 동향)

  • Jeon, Seulki;Shin, Hyuna;Kim, Dong-Jin
    • Clean Technology
    • /
    • v.24 no.2
    • /
    • pp.87-98
    • /
    • 2018
  • Phosphorus (P) is an essential and irreplaceable element for all living organisms, and it is widely used as a fertilizer. Unfortunately, it is estimated that phosphate reservoir is depleted within about 100 years. Sewage sludge ash (SSA) is an alternative resource for P recovery because of its high P content. However, SSA cannot be directly used as a fertilizer due to heavy metals in it and low P bioavailability. Thermochemical treatment with Cl donor is known to reduce heavy metal contents and increase P bioavailability of SSA. Literature review on thermochemical technologies of SSA for the reduction of heavy metals and bioavailability enhancement has been carried out to estimate the status of current P recovery technology and to develop strategic future research plan for P recovery. The review showed that $CaCl_2$ and $MgCl_2$ were the most effective Cl donors and reaction temperature (< $1000^{\circ}C$) was the critical operation condition for the reduction. The removal efficiency depends on the species of heavy metals. Thermochemical technology of SSA for P recovery showed the possibility of commercial application in the near future to overcome the coming crisis of human sustainability by P depletion, but it needs cost effectiveness and more ecofriendly process to reduce energy consumption.